title: The effects of progesterone pretreatment on the response to oral d-amphetamine in Women.
abstract: Stimulant abuse continues to be a problem, particularly for women. There is increasing preclinical and clinical evidence showing that the hormone progesterone attenuates the behavioral effects of cocaine, and this effect is primarily observed in females. The purpose of the present study was to determine if progesterone would also alter the behavioral effects of another stimulant, oral d-amphetamine (AMPH) in women. Eighteen normal non-drug abusing women completed eight outpatient sessions over two menstrual cycles. During the follicular phase of each cycle, women were administered AMPH (0, 10, 20 mg); in one cycle they were pretreated with oral micronized progesterone (200 mg) and in another cycle they were pretreated with placebo progesterone. Each session, participants completed a range of tasks including subjective measures of abuse liability, cognitive performance tasks, and behavioral measures of impulsivity and risk-taking. AMPH produced dose-related increases in positive subjective effects and these effects were enhanced by progesterone pretreatment. AMPH alone, or in combination with progesterone, had little effect on performance or behavioral measures of impulsivity. These results are in contrast with previous studies showing that progesterone attenuates the subjective response to cocaine and nicotine. Additional studies are needed to explore the modulatory role of progesterone on the effects of AMPH to determine whether progesterone has any clinical utility for AMPH abuse.
authors.affiliation: Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA. sc2432@columbia.edu
authors.forename: Stephanie C
authors.initials: SC
authors.lastname: Reed
authors.forename: Frances R
authors.initials: FR
authors.lastname: Levin
authors.forename: Suzette M
authors.initials: SM
authors.lastname: Evans
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D003071:Cognition / Q000187:drug effects*; D003913:Dextroamphetamine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007175:Impulsive Behavior; D008597:Menstrual Cycle; D010919:Placebos; D011374:Progesterone / Q000008:administration & dosage*; D012309:Risk-Taking
chemical_list: D000697:Central Nervous System Stimulants; D010919:Placebos; D011374:Progesterone; D003913:Dextroamphetamine
references.citation: Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33
references.pmid: 17469936
references.citation: Psychopharmacology (Berl). 2007 Jun;192(2):171-82
references.pmid: 17265075
references.citation: Behav Brain Res. 1989 Nov 1;35(2):117-25
references.pmid: 2818831
references.citation: Drug Alcohol Depend. 2007 Jul 10;89(2-3):183-9
references.pmid: 17240083
references.citation: J Clin Psychol. 1995 Nov;51(6):768-74
references.pmid: 8778124
references.citation: Brain Res Bull. 2006 Jan 30;68(5):310-4
references.pmid: 16377436
references.citation: Exp Clin Psychopharmacol. 2007 Dec;15(6):599-609
references.pmid: 18179313
references.citation: Behav Res Methods Instrum Comput. 2002 Aug;34(3):391-8
references.pmid: 12395555
references.citation: Pharmacol Biochem Behav. 2002 Nov;73(4):729-41
references.pmid: 12213517
references.citation: Pharmacol Biochem Behav. 2002 May;72(1-2):431-5
references.pmid: 11900816
references.citation: J Child Psychol Psychiatry. 2003 Nov;44(8):1145-57
references.pmid: 14626456
references.citation: Exp Clin Psychopharmacol. 1999 Aug;7(3):274-83
references.pmid: 10472516
references.citation: Clin Ther. 1999 Jan;21(1):41-60; discussion 1-2
references.pmid: 10090424
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1995 May;19(3):491-7
references.pmid: 7624499
references.citation: Alcohol Clin Exp Res. 1993 Feb;17(1):140-6
references.pmid: 8452195
references.citation: Neuroendocrinology. 1990 Nov;52(5):517-20
references.pmid: 2126359
references.citation: J Exp Psychol Gen. 1999 Mar;128(1):78-87
references.pmid: 10100392
references.citation: Brain Res. 2008 Jan 16;1189:229-35
references.pmid: 18067879
references.citation: Horm Behav. 2010 Jun;58(1):13-21
references.pmid: 19733571
references.citation: Psychoneuroendocrinology. 2004 Apr;29(3):339-54
references.pmid: 14644065
references.citation: J Stud Alcohol. 2002 Jan;63(1):83-90
references.pmid: 11925063
references.citation: Behav Neurosci. 2000 Aug;114(4):830-7
references.pmid: 10959541
references.citation: Am J Psychiatry. 2009 Oct;166(10):1170-7
references.pmid: 19723785
references.citation: Psychopharmacology (Berl). 2001 Mar;154(3):243-50
references.pmid: 11351931
references.citation: Behav Genet. 2010 Mar;40(2):255-61
references.pmid: 20091113
references.citation: Psychopharmacology (Berl). 2005 Jul;180(2):294-305
references.pmid: 15717210
references.citation: Psychopharmacology (Berl). 2006 Nov;189(1):17-25
references.pmid: 16972106
references.citation: Horm Behav. 2010 Jun;58(1):44-56
references.pmid: 19818789
references.citation: Pharmacotherapy. 2007 May;27(5):666-74
references.pmid: 17461701
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):418-26
references.pmid: 17924776
references.citation: Neuropsychopharmacology. 1998 Dec;19(6):499-516
references.pmid: 9803426
references.citation: Fertil Steril. 1993 Jul;60(1):26-33
references.pmid: 8513955
references.citation: Drug Alcohol Depend. 2008 Jul 1;96(1-2):111-20
references.pmid: 18378098
references.citation: Psychopharmacology (Berl). 2002 Feb;159(4):397-406
references.pmid: 11823892
references.citation: Hum Psychopharmacol. 2003 Jun;18(4):291-9
references.pmid: 12766934
references.citation: Neuropsychopharmacology. 2005 Apr;30(4):669-82
references.pmid: 15688093
references.citation: Drug Alcohol Depend. 2005 Feb 14;77(2):151-9
references.pmid: 15664716
references.citation: Hum Psychopharmacol. 2009 Oct;24(7):559-64
references.pmid: 19743227
references.citation: Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):299-304
references.pmid: 11420098
references.citation: Psychoneuroendocrinology. 2006 Nov;31(10):1190-9
references.pmid: 17034954
references.citation: J Pers Assess. 1996 Dec;67(3):588-97
references.pmid: 8991972
references.citation: Pharmacol Biochem Behav. 2005 Jul;81(3):559-68
references.pmid: 15936062
references.citation: Psychon Bull Rev. 1996 Mar;3(1):100-4
references.pmid: 24214810
references.citation: Front Neuroendocrinol. 2002 Jan;23(1):41-100
references.pmid: 11906203
references.citation: Trends Pharmacol Sci. 2004 May;25(5):273-9
references.pmid: 15120494
references.citation: J Reprod Med. 1995 Jul;40(7):521-4
references.pmid: 7473442
references.citation: J Pharmacol Exp Ther. 1994 Nov;271(2):683-94
references.pmid: 7965783
references.citation: Psychoneuroendocrinology. 2009 Apr;34(3):343-52
references.pmid: 18977603
references.citation: J Exp Psychol Appl. 2002 Jun;8(2):75-84
references.pmid: 12075692
references.citation: Psychopharmacology (Berl). 1999 Jul;145(1):67-75
references.pmid: 10445374
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):472-80
references.pmid: 17924781
references.citation: Neuropsychopharmacology. 2006 Mar;31(3):659-74
references.pmid: 16160708
references.citation: Pharmacol Biochem Behav. 2004 Aug;78(4):699-705
references.pmid: 15301924
references.citation: Behav Pharmacol. 1993 Feb;4(1):3-13
references.pmid: 11224166
references.citation: Appetite. 1999 Jun;32(3):331-49
references.pmid: 10336792
references.citation: Psychopharmacology (Berl). 2009 Mar;203(1):63-72
references.pmid: 18998113
references.citation: Neuropsychopharmacology. 2006 Jan;31(1):129-38
references.pmid: 15920500
references.citation: J Am Pharm Assoc (2003). 2009 Jul-Aug;49(4):519-28
references.pmid: 19589764
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):445-52
references.pmid: 17924778
references.citation: FASEB J. 1992 Mar;6(6):2311-22
references.pmid: 1347506
references.citation: Exp Clin Psychopharmacol. 2010 Feb;18(1):78-86
references.pmid: 20158297
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):453-60
references.pmid: 17924779
references.citation: J Consult Clin Psychol. 1978 Feb;46(1):139-49
references.pmid: 627648
references.citation: Psychiatry Res. 1998 Jan 16;77(1):35-42
references.pmid: 10710173
references.citation: Br J Clin Pharmacol. 1992 Mar;33(3):293-8
references.pmid: 1576050
references.citation: Neuropsychopharmacology. 2007 Sep;32(9):1956-66
references.pmid: 17251908
references.citation: Drug Alcohol Depend. 2004 May 10;74(2):147-58
references.pmid: 15099658
references.citation: Psychopharmacology (Berl). 1989;98(3):408-11
references.pmid: 2501818
references.citation: Drug Alcohol Depend. 2010 Mar 1;107(2-3):264-7
references.pmid: 20005642
references.citation: Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):258-66
references.pmid: 17544491
references.citation: Neuropsychopharmacology. 2002 Nov;27(5):813-25
references.pmid: 12431855
references.citation: Pharmacol Biochem Behav. 2009 Sep;93(3):337-42
references.pmid: 19447128
references.citation: Pharmacol Biochem Behav. 1982 Jun;16(6):875-9
references.pmid: 7202216
references.citation: Behav Res Methods. 2005 Feb;37(1):82-90
references.pmid: 16097347
references.citation: Psychopharmacology (Berl). 2000 May;150(1):90-101
references.pmid: 10867981
references.citation: J Neurosci. 2005 Apr 13;25(15):3932-9
references.pmid: 15829645
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1847-55
references.pmid: 17851535
references.citation: Exp Clin Psychopharmacol. 2007 Oct;15(5):461-71
references.pmid: 17924780
references.citation: Subst Use Misuse. 2004 Jun;39(7):1095-116
references.pmid: 15387205
references.citation: Psychoneuroendocrinology. 2001 Oct;26(7):697-710
references.pmid: 11500251
references.citation: Addict Behav. 2007 Jun;32(6):1177-88
references.pmid: 17011712